(Click to play video.)
Cybin Inc. (NEO: CYBN, NYSE: CYBN, Forum) is a Toronto-based life sciences company initially focused on psychedelic pharmaceutical therapies supporting research to advance psychedelic therapies centered on improving mental health and wellbeing.
The biotech company utilizes proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches, and potential treatment regimens for psychiatric disorders. Click the video above to learn more about Cybin's operations.
To find out more about the company, visit
cybin.com.
FULL DISCLOSURE: Cybin Inc. is a client of Stockhouse Publishing.